NXG's offering is closing soon. The discount remains narrower than -10%, so it makes sense to subscribe. Strong NAV performance likely contributed to steady discount valuation. Briefly, this is a ...
The Rights Offering is fully backstopped by Abrams Capital and BC Partners Credit, pursuant to the previously disclosed backstop agreements at an effective purchase price of $8.00 per share.
Please try using other words for your search or explore other sections of the website for relevant information. This press release does not constitute an offer to sell or a solicitation of an offer to ...
AIM ImmunoTech Inc. (NYSE American: AIM) - AIM ImmunoTech Inc. ('AIM” or the 'Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of ...
Please try using other words for your search or explore other sections of the website for relevant information. The proceeds of the Rights Offering are expected to be used for inventory purchases, ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse” or the “Company”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) ...
Vancouver, British Columbia– TheNewswire – November 27, 2025 — Plantify Foods, Inc. (PTFY:CA) ("Plantify Foods" or the "Company") announces that it intends toissue rights (the "Rights Offering") to ...
Pursuant to the Rights Offering, the Company will be offering 1,487,151,720 rights (the “Rights”) to certain holders (the “Shareholders”) of common shares in the capital of Ascot (the “Common Shares”) ...
CALGARY, Alberta, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Calfrac Well Services Ltd. ("Calfrac" or "the Company") (TSX: CFW) is pleased to announce that it is commencing a rights offering (the "Rights ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse” or the “Company”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) ...
AIM ImmunoTech Inc. (NYSE American: AIM) - AIM ImmunoTech Inc. ('AIM” or the 'Company”), an immuno-pharma company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results